Cargando…

The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools

The hippocampus is one of the earliest sites involved in the pathology of Alzheimer's disease (AD). Therefore, we specifically investigated the sensitivity and specificity of hippocampal volume and glucose metabolism in patients being evaluated for AD, using automated quantitative tools (NeuroQ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Bruna Letícia, Neto, Guilherme de Carvalho Campos, Nucci, Mariana Penteado, Mamani, Javier Bustamante, Lacerda, Shirley Silva, Felício, André Carvalho, Amaro, Edson, Gamarra, Lionel Fernel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855664/
https://www.ncbi.nlm.nih.gov/pubmed/31702636
http://dx.doi.org/10.1097/MD.0000000000017824
_version_ 1783470449282252800
author Ferrari, Bruna Letícia
Neto, Guilherme de Carvalho Campos
Nucci, Mariana Penteado
Mamani, Javier Bustamante
Lacerda, Shirley Silva
Felício, André Carvalho
Amaro, Edson
Gamarra, Lionel Fernel
author_facet Ferrari, Bruna Letícia
Neto, Guilherme de Carvalho Campos
Nucci, Mariana Penteado
Mamani, Javier Bustamante
Lacerda, Shirley Silva
Felício, André Carvalho
Amaro, Edson
Gamarra, Lionel Fernel
author_sort Ferrari, Bruna Letícia
collection PubMed
description The hippocampus is one of the earliest sites involved in the pathology of Alzheimer's disease (AD). Therefore, we specifically investigated the sensitivity and specificity of hippocampal volume and glucose metabolism in patients being evaluated for AD, using automated quantitative tools (NeuroQuant – magnetic resonance imaging [MRI] and Scenium – positron emission tomography [PET]) and clinical evaluation. This retrospective study included adult patients over the age of 45 years with suspected AD, who had undergone fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET-CT) and MRI. FDG-PET-CT images were analyzed both qualitatively and quantitatively. In quantitative volumetric MRI analysis, the percentage of the total intracranial volume of each brain region, as well as the total hippocampal volume, were considered in comparison to an age-adjusted percentile. The remaining brain regions were compared between groups according to the final diagnosis. Thirty-eight patients were included in this study. After a mean follow-up period of 23 ± 11 months, the final diagnosis for 16 patients was AD or high-risk mild cognitive impairment (MCI). Out of the 16 patients, 8 patients were women, and the average age of all patients was 69.38 ± 10.98 years. Among the remaining 22 patients enrolled in the study, 14 were women, and the average age was 67.50 ± 11.60 years; a diagnosis of AD was initially excluded, but the patients may have low-risk MCI. Qualitative FDG-PET-CT analysis showed greater accuracy (0.87), sensitivity (0.76), and negative predictive value (0.77), when compared to quantitative PET analysis, hippocampal MRI volumetry, and specificity. The positive predictive value of FDG-PET-CT was similar to the MRI value. The performance of FDG-PET-CT qualitative analysis was significantly more effective compared to MRI volumetry. At least in part, this observation could corroborate the sequential hypothesis of AD pathophysiology, which posits that functional changes (synaptic dysfunction) precede structural changes (atrophy).
format Online
Article
Text
id pubmed-6855664
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68556642019-11-26 The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools Ferrari, Bruna Letícia Neto, Guilherme de Carvalho Campos Nucci, Mariana Penteado Mamani, Javier Bustamante Lacerda, Shirley Silva Felício, André Carvalho Amaro, Edson Gamarra, Lionel Fernel Medicine (Baltimore) 6800 The hippocampus is one of the earliest sites involved in the pathology of Alzheimer's disease (AD). Therefore, we specifically investigated the sensitivity and specificity of hippocampal volume and glucose metabolism in patients being evaluated for AD, using automated quantitative tools (NeuroQuant – magnetic resonance imaging [MRI] and Scenium – positron emission tomography [PET]) and clinical evaluation. This retrospective study included adult patients over the age of 45 years with suspected AD, who had undergone fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET-CT) and MRI. FDG-PET-CT images were analyzed both qualitatively and quantitatively. In quantitative volumetric MRI analysis, the percentage of the total intracranial volume of each brain region, as well as the total hippocampal volume, were considered in comparison to an age-adjusted percentile. The remaining brain regions were compared between groups according to the final diagnosis. Thirty-eight patients were included in this study. After a mean follow-up period of 23 ± 11 months, the final diagnosis for 16 patients was AD or high-risk mild cognitive impairment (MCI). Out of the 16 patients, 8 patients were women, and the average age of all patients was 69.38 ± 10.98 years. Among the remaining 22 patients enrolled in the study, 14 were women, and the average age was 67.50 ± 11.60 years; a diagnosis of AD was initially excluded, but the patients may have low-risk MCI. Qualitative FDG-PET-CT analysis showed greater accuracy (0.87), sensitivity (0.76), and negative predictive value (0.77), when compared to quantitative PET analysis, hippocampal MRI volumetry, and specificity. The positive predictive value of FDG-PET-CT was similar to the MRI value. The performance of FDG-PET-CT qualitative analysis was significantly more effective compared to MRI volumetry. At least in part, this observation could corroborate the sequential hypothesis of AD pathophysiology, which posits that functional changes (synaptic dysfunction) precede structural changes (atrophy). Wolters Kluwer Health 2019-11-11 /pmc/articles/PMC6855664/ /pubmed/31702636 http://dx.doi.org/10.1097/MD.0000000000017824 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6800
Ferrari, Bruna Letícia
Neto, Guilherme de Carvalho Campos
Nucci, Mariana Penteado
Mamani, Javier Bustamante
Lacerda, Shirley Silva
Felício, André Carvalho
Amaro, Edson
Gamarra, Lionel Fernel
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title_full The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title_fullStr The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title_full_unstemmed The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title_short The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools
title_sort accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected alzheimer's disease, using automatic quantitative clinical tools
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855664/
https://www.ncbi.nlm.nih.gov/pubmed/31702636
http://dx.doi.org/10.1097/MD.0000000000017824
work_keys_str_mv AT ferraribrunaleticia theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT netoguilhermedecarvalhocampos theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT nuccimarianapenteado theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT mamanijavierbustamante theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT lacerdashirleysilva theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT felicioandrecarvalho theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT amaroedson theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT gamarralionelfernel theaccuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT ferraribrunaleticia accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT netoguilhermedecarvalhocampos accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT nuccimarianapenteado accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT mamanijavierbustamante accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT lacerdashirleysilva accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT felicioandrecarvalho accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT amaroedson accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools
AT gamarralionelfernel accuracyofhippocampalvolumetryandglucosemetabolismforthediagnosisofpatientswithsuspectedalzheimersdiseaseusingautomaticquantitativeclinicaltools